Datavault AI Inc. (NASDAQ: DVLT) has announced a binding term sheet with Wellgistics Health (NASDAQ: WGRX) to form DelivMeds AI, a healthcare platform that integrates AI-driven pharmacy optimization, blockchain-enabled smart contracts, biometric verification, and direct-to-consumer healthcare delivery. The venture is valued at approximately $4 billion, subject to an independent fairness opinion, and aims to support a national rollout of data-driven healthcare solutions.
The partnership involves three concurrent transactions: an expanded PharmacyChain(TM) license, acquisition of QOLPOM intellectual property, and a controlling stake in Tollo Health. These moves are designed to create a comprehensive platform that leverages advanced technologies to improve patient engagement and healthcare delivery. According to the announcement, DelivMeds AI will utilize Datavault AI’s expertise in data valuation and monetization, combined with Wellgistics’ healthcare distribution network.
Datavault AI’s technology suite includes AI and machine learning automation, third-party integration, and detailed analytics. The company’s Acoustic Sciences division features WiSA(R), ADIO(R), and Sumerian(R) patented technologies for spatial audio, while the Data Science division focuses on Web 3.0 solutions for data perception and secure monetization. The platform serves industries such as sports, entertainment, biotech, fintech, real estate, healthcare, and energy.
Wellgistics Health brings its pharmacy and healthcare logistics capabilities to the venture. The partnership aims to address inefficiencies in the healthcare system by providing a seamless, technology-driven approach to prescription management and patient care. Blockchain-enabled smart contracts will ensure transparency and security, while biometric verification adds a layer of identity authentication for patients.
The expected $4 billion asset value underscores the potential scale of the venture. Investors can find more details about Datavault AI in the company’s newsroom at https://ibn.fm/DVLT. The full press release is available at https://ibn.fm/yIVh9.
This development marks a significant step in the convergence of AI, blockchain, and healthcare. By combining these technologies, DelivMeds AI aims to create a new standard for patient-centric care, potentially reducing costs and improving outcomes. The national rollout could reshape how pharmacies and healthcare providers interact with patients, leveraging real-time data and secure transactions.
Datavault AI is headquartered in Philadelphia, Pennsylvania, and its cloud-based platform provides comprehensive solutions for data experiences and monetization. The company’s Information Data Exchange(R) enables Digital Twins and licensing of name, image, and likeness by anchoring to immutable metadata. Wellgistics Health operates in the healthcare logistics sector, focusing on pharmacy benefit management and distribution.
The announcement highlights the growing trend of technology companies entering the healthcare space, seeking to apply AI and blockchain to solve long-standing challenges. As the venture moves forward, it will be subject to regulatory approvals and the completion of the fairness opinion. The partnership represents a bold bet on the integration of cutting-edge technologies in a traditionally slow-to-change industry.
This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Datavault AI and Wellgistics Health Launch DelivMeds AI Venture Valued at $4 Billion.